Track market-moving stories before they get noisy

After consolidating within a narrow range early in July, DeXe [DEXE] skyrocketed to a new all-time high of $49.40. The rally was driven by the successful rollout of the Dexelization AI integration upgrade, which triggered the move to ATH.

The upgrade embeds specialized AI agents into the protocol infrastructure, enabling AI and users to collaborate in operation and management. However, the market buzz around it faded after the altcoin reached ATH, resulting in a rejection. Since then, the altcoin has printed four red candles, closing at new lows each day.

At press time, DEXE traded around $34, down 9.85% on the daily charts. Over the same period, altcoin volume jumped 58% to $158 million, suggesting intense selling pressure.

DEXE whales are making moves Interestingly, after DEXE began to decline, whales re-entered the market. Spot Average Order Size data from CryptoQuant showed Big Whale Orders for three consecutive days. 

Source: CryptoQuant When this metric shows whale orders, it suggests increased market participation from the cohort either selling or buying.  Notably, the Spot Taker CVD highlighted that these whales have been actively cashing out. 

The Spot Taker CVD metric has remained red for five consecutive days, indicating that more sell orders have recently been executed on the spot. 

Source: CryptoQuant Therefore, it’s most likely that these whales have mostly been closing their positions. Furthermore, the exchange flow also echoed this selling trend. According to CoinGlass data, DEXE’s netflow has remained positive over the past week. 

For example, over the last three days, $33.1 million in DEXE has entered exchanges, while $26.27 million has left. 

Source: Coinglass As a result, the Spot Netflow climbed to $6.8 million, a trend that has continued as of this writing. A sustained period of positive net flow suggests that sellers are more incentivized to exit the market. 

Often, such market conditions have preceded extended market weakness, leading to more losses on price charts.

Is DEXE at risk of more losses? DEXE is currently experiencing strong downward pressure, largely driven by whale bearishness. As a result, downside market momentum strengthened significantly.

At press time, the Stochastic Momentum Index (SMI) crashed into oversold territory, falling from 77 to 27. At such low levels, the SMI indicated the downside momentum is especially strong.

Source: TradingView At the same time, the Relative Strength Index (RSI) formed a bearish crossover, falling from 70 to 58 at press time. This showed that although buyers remain active, sellers managed to retake the market.

Typically, such market conditions have preceded a price drop. Thus, if investors, especially whales, continue to offload, DEXE could drop below $30. However, if the market manages to hold between $37 and $40, this bearish outlook will be invalidated.

Final Summary DeXe extended its bearish structure, dropping 9.85% to a low of $32 before slightly rebounding.  The DEXE market showed weakness, largely driven by bearish whales who have been aggressively selling. 

Greg Abel has a tough act to follow in replacing investing legend Warren Buffett as CEO of Berkshire Hathaway. But Abel has already shown, in just a few months on the job, that he is not afraid to make changes.

One of his biggest is boosting Berkshire's position in Alphabet, which now makes up about 9% of the portfolio and is a top-five holding. The combination of Apple and Alphabet accounts for almost 30% of the Berkshire Hathaway portfolio.

But right now, an old Buffett play, Kroger (KR 3.71%), might be one of the better Berkshire Hathaway stocks to own. Here's why.

Image source: The Motley Fool.

Why Kroger is a sneaky good buy Kroger, the nation's largest grocery store chain, has been in the Berkshire Hathaway portfolio since 2019. Last quarter, it made up about 1.4% of the portfolio, with no shares bought or sold by Abel.

Kroger is a classic defensive play. Groceries are needed whether the economy is good, bad, or somewhere in between. So, as the largest grocery store chain, it is built to outperform during an extended market dip. In the 2022 bear market, Kroger stocks held up well, down about 1% in a year when the S&P 500 (^GSPC +0.38%) was off 19% and the Nasdaq Composite (^IXIC +0.62%) sank 33%.

This year has been a microcosm of Kroger's defensive attributes. In the first quarter, when the Nasdaq entered a correction and the S&P 500 was down, Kroger stock rose by some 21% to more than $75 per share in March.

Today's Change

(

-3.71

%) $

-2.18

Current Price

$

56.56

Then, as the market stormed back in April and May, Kroger shares sank back down to their current $58 per share, down around 5% year to date. It hit a 52-week low of $55 per share at the end of June. It is currently trading at about 34 times earnings but just 11 times forward earnings. Its five-year PEG ratio is even lower at 0.57, well below 1, which means it is undervalued.

Trading near a 52-week low It's hard to say when the market will undergo another correction, but valuations have surged back up, and economic indicators remain somewhat weak. Investors should be cautious and focused on building a carefully balanced and diversified portfolio.

That's where Kroger comes in. This is a great time to add a strong defensive stock to your portfolio at a 52-week low to have that downside protection during the next dip.

Wall Street is bullish on Kroger, with analysts setting a median price target of $72.50 per share. That would represent about 24% upside over the next 12 months.

In addition, Kroger has an excellent dividend, yielding 2.63% with a low payout ratio of 21%. That suggests the company has more room to increase that dividend. Kroger has consistently raised its dividend over the years, with 19 straight years of annual dividend increases.

Kroger may not be glitzy like a "Magnificent Seven" stock or a highflier, but right now is a particularly good time to buy this strong defensive stock.

Reports of Bankruptcy are Far From the Facts, Silvio Napoli SaysNapoli said that the automaker was “not considering bankruptcy or a transaction to take the company private,” and said that the reports were “false.” He said that the Board has also not explored any such scenarios.

“As disclosed in our most recent quarterly filing, Lucid has sufficient liquidity to fund its operations well into next year,” Napoli said. He added that the outside advisors had not advised the company to file for bankruptcy and that reports of any such advice were also untrue.

“My priority is clear: turn this company around. That is where the leadership team and I are focused,” Napoli said, adding that the company will be “providing a full update” during its upcoming earnings call.

Source: Silvio Napoli via LinkedIn

Lucid stock has been volatile since the beginning of the year. Year-to-date (YTD), Lucid stock has fallen nearly 44% to just under $6 per share.

However, following the CEO, as well as the company’s pushback against the reports, LCID rebounded over 28% and currently trades for $5.95 per share during pre-market trading on Thursday.

For the second quarter of 2026, the automaker produced 4,774 vehicles and delivered 3,953 units, amid a series of changes in its leadership.

According to Benzinga Edge Rankings, Lucid provides a favorable price trend in the Short term.

Check out more of Benzinga’s Future Of Mobility coverage by following this link.

Photo courtesy: Ian Dewar Photography / Shutterstock.com

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

The Strait of Hormuz, which handles roughly a quarter of the world's maritime oil trade, has been closed since Feb. 28. That closure drove up crude oil prices and lifted many oil stocks, but squeezed shares of companies that relied on lower fuel costs.

However, several electric vehicle (EV) stocks have risen since the Strait's closure. Let's see why that happened, and which EV stocks will benefit the most from higher oil prices.

Image source: Getty Images.

Which EV stocks have performed well since Feb. 28? Higher oil prices can make it more expensive to produce and transport EVs, but they also make them more appealing to consumers who want to escape oil's cyclical swings. That's why the global EV market could grow at a 10% CAGR from 2026 to 2034, according to Fortune Business Insights, and why several top EV stocks are still promising long-term investments.

Today's Change

(

1.71

%) $

0.30

Current Price

$

17.80

One of those top performers was Rivian (RIVN +1.71%), which has risen 16% since Feb. 28. That rally was fueled by the launch of its R2 SUV, which costs significantly less than its R1T pickup and R1S SUV. The R2 also costs less to manufacture than its predecessors, so its increased sales should actually boost its gross margin rather than compress it.

Rivian expects the R2's launch to boost its annual deliveries from 42,247 vehicles in 2025 to 62,000-67,000 vehicles in 2026. Analysts expect its revenue to triple from 2025 to 2028 as it narrows its net losses. That's an impressive outlook for a stock that trades at less than four times this year's sales. Therefore, it could be revalued as a growth play over the next few years.

Today's Change

(

0.80

%) $

0.04

Current Price

$

5.05

Another resilient EV stock was Nio (NIO +0.80%). The Chinese EV maker's stock has risen about 4% since Feb. 28, and it still looks like a screaming bargain at less than one times this year's sales. Nio stands out in the EV market because its vehicles use swappable batteries that can be quickly swapped out, offering a faster alternative to charging at its own battery-swapping stations. It also sells cheaper SUVs and compact cars via its ONVO and Firefly sub-brands.

From 2025 to 2028, analysts expect Nio's revenue to roughly double. They also expect it to finally turn profitable in 2027 as it divests its lower-margin businesses, grows Nio's share of the higher-margin premium sedan market, and scales its cheaper ONVO and Firefly sub-brands.

Should you buy either of these EV stocks today? Rivian and Nio are still speculative stocks, but both look undervalued and well-positioned to profit from the EV market's long-term expansion. They're well-insulated from higher oil prices, and they'll keep growing as more consumers ditch their gas-powered vehicles.

U.S. stock futures declined on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices fell, following Wednesday’s higher close.

President Donald Trump said Iran wants to negotiate even as U.S. forces launched a second wave of strikes against Iranian military targets.

Meanwhile, the U.S. Treasury announced new sanctions targeting an international network accused of procuring weapons for Iran’s Islamic Revolutionary Guard Corps following attacks on commercial vessels in the Strait of Hormuz.

Meanwhile, the 10-year Treasury bond yielded 4.57%, and the two-year bond was at 4.15%. The CME Group’s FedWatch tool’s projections show markets pricing an 89.8% likelihood of the Federal Reserve leaving the current interest rates unchanged during July’s meeting.

IndexPerformance (+/-)Dow Jones-0.01%S&P 500-0.08%Nasdaq 100-0.36%Russell 2000-0.28%Stocks In FocusJB Hunt Transport Services Benzinga’s Edge Stock Rankings indicate that JBHT maintains a strong price trend in the short, long, and medium terms, with a moderate quality score. Agape ATP Agape ATP Corp. (NASDAQ:ATPC) surged 55.56% following the Securities and Exchange Commission filing that disclosed a new stake held by proprietary trading firm and liquidity provider Jane Street Group LLC. Benzinga’s Edge Stock Rankings indicate that ATPC maintains a weak price trend in the short, long, and medium terms. AST SpaceMobile AST SpaceMobile Inc. (NASDAQ:ASTS) tumbled 10.01% after the company announced a $1.0 billion proposed public offering of Convertible Senior Notes. Benzinga’s Edge Stock Rankings indicate that ASTS maintains a weak price trend in the long, short, and medium terms. Growhub Growhub Ltd. (NASDAQ:TGHL) gained 33.89% after the company announced a $400 million merger agreement with EnChem. Benzinga’s Edge Stock Rankings indicate that TGHL maintains a weak price trend in the long term but a strong trend in the short and medium terms. Benzinga’s Edge Stock Rankings indicate that ATAI maintains a strong price trend in the short, long, and medium terms. Cues From Last SessionConsumer discretionary, financial, and communication services stocks recorded the biggest gains on Wednesday, while utilities and energy stocks bucked the overall market trend, closing the session lower.

Insights From AnalystsBlackRock remains tactically constructive on the U.S. stock market while navigating a fundamentally transformed economic landscape. In its commentary, the firm maintains an overweight position on U.S. equities, noting that “strong corporate earnings, fueled by the AI buildout and a favorable macro backdrop, are outpacing higher interest rate expectations.”

Within equities, BlackRock advises focusing closely on AI bottleneck opportunities such as power, chips, and data centers.

Regarding the broader economy and policy environment, BlackRock emphasizes that a structural shift has taken hold, reinforcing its view that “the global rates reset is real and significant.”

The firm cautions that underlying inflation remains too firm to confidently return to the Federal Reserve’s 2% target, which will likely keep the central bank on hold.

In this “new regime” of elevated rates, fixed-income dynamics have changed. While higher yields have made durable income an opportunity again,

BlackRock warns that long-term bonds are “less reliable diversifiers”. Consequently, the firm prefers the front end and belly of the U.S. yield curve, advising investors to target areas where they are best compensated for risk.

Upcoming Economic DataHere’s what investors will be keeping an eye on this Thursday.

Commodities, Crypto, And Global Equity MarketsCrude Oil WTI futures were trading lower in the early New York session by 0.08% to hover around $79.54 per barrel.

Gold Spot US Dollar fell 0.65% to hover around $4,033.80 per ounce. The U.S. Dollar Index spot was 0.05% higher at the 100.5320 level.

Meanwhile, Bitcoin (CRYPTO: BTC) was trading 1.00% lower at $64,042.02 per coin over the last 24 hours.

Asian markets closed mostly lower on Wednesday, except Hong Kong’s Hang Seng and India’s Nifty 50 indices. China’s CSI 300, Australia’s ASX 200, South Korea’s Kospi, and Japan’s Nikkei 225 indices fell. European markets were mostly lower in early trade.

Photo courtesy: Frontpage / Shutterstock.com

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Space stocks are on many investors' minds these days, but going all-in on this sector right now comes with considerable risk, as most rocket stocks are volatile.

Still, two stocks that are no doubt near the top of many investors' watch lists are Space Exploration Technologies (SPCX 0.59%) and Rocket Lab (RKLB 3.36%). Here's which one looks like the better buy right now.

Image source: Getty Images.

The case for SpaceX What was once just a rocket company has morphed into an expanding technology behemoth with its sights set on both the space and artificial intelligence (AI) markets.

SpaceX has highly ambitious goals for both, including colonizing Mars, launching orbital data centers, expanding its Starlink satellite internet business, and building what some analysts are calling a "sovereign AI" platform in which the company controls the AI model, chip designs, processor manufacturing, and everything in between.

That's part of the appeal of SpaceX for some investors -- the company is trying big things, like developing its Starship rocket, which it says will reduce the costs of putting payloads into orbit by at least 90%, or deploying a constellation of data center satellites. Morningstar research puts the total addressable market for its Starlink connectivity business at $129 billion.

And the company is making headway on some of its goals. It has 12 million Starlink internet subscribers and generated $1.9 billion in operating profit from that business in the most recent quarter.

SpaceX is also making progress with its neocloud business, which leases data center capacity (Earth-bound, for now) to tech companies including Alphabet and Anthropic. That business has already signed more than $81 billion in contracts.

And then there's the potential for SpaceX to merge with Elon Musk's other large company, Tesla. That could expand SpaceX's opportunities into the autonomous vehicle and humanoid robot markets, the latter of which could be worth $3 trillion by 2050, according to a Morgan Stanley forecast.

Today's Change

(

-0.59

%) $

-0.81

Current Price

$

135.27

The case for Rocket Lab There's some overlap between Rocket Lab and SpaceX, though Rocket Lab isn't building AI data centers or planning to merge with a humanoid robotics company (as of now).

The company is instead mostly focused on launching rockets for its customers and on expanding its satellite communications network through its recently announced purchase of Iridium Communications.

Rocket Lab has agreed to pay $8 billion for Iridium, and is expected to close on the deal next year, giving it 2.5 million satellite-based mobile subscribers. The service is mainly geared toward the private and government sectors, in contrast to Starlink, which caters more to customers who want at-home internet service.

Iridium is profitable, with $114 million in net earnings last year, and the deal will help Rocket Lab expand its satellite communications network to better compete with SpaceX.

But Rocket Lab's primary business is sending payloads into space, and in the first quarter, the company signed 31 new deals, selling more launches than it did in all of 2025.

The company also has some major launch contracts already signed, including with the U.S. government to establish the satellite system for the proposed Golden Dome missile defense system. It also has contracts for missile tracking and military communications.

Today's Change

(

-3.36

%) $

-2.65

Current Price

$

76.16

While Rocket Lab isn't profitable, its loss of $0.07 per share in Q1 was an improvement from its loss of $0.12 per share in the prior-year quarter. Revenue is also growing at a healthy clip, rising 64% to $200 million.

In contrast, SpaceX's sales rose just 15% in Q1 to $4.7 billion, and the company's loss of $3.29 per share was dramatically worse than its $0.41 per share loss in the year-ago quarter.

SpaceX's massive losses have been fueled by sharp increases in its capital expenditures, which reached $10 billion in Q1 2026 alone, compared to $27 billion for all of 2025.

That heavy spending should give investors pause, and so should the lofty valuation of its stock. SpaceX trades at a price-to-sales (P/S) ratio of about 94 compared to Rocket Lab's P/S ratio of 66.

While neither stock is cheap, SpaceX's shares trade at a much higher premium even as the company ramps up spending and its losses widen. All of which means that Rocket Lab looks like the better space stock to buy right now.

Viasat experts demonstrate satellite-enabled voice call capabilities as part of research collaboration 
during this week’s 5G Automotive Association Meeting Week in Munich, Germany: for the first time integrated with the infotainment system of a BMW iX3.

Showcase highlights what might be possible in future and the potential for reliable voice and messaging connectivity beyond the reach of traditional terrestrial networks.

MUNICH, July 16, 2026 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced a landmark technology demonstration showcasing the first automotive satellite voice call demonstration fully integrated into a BMW Group vehicle’s platform.

It marks a significant step forward as Viasat brings Non-Terrestrial Network (NTN) communications into the connected vehicle ecosystem: enabling drivers and passengers to stay connected in remote or underserved areas where cellular coverage may be limited or unavailable.

Building on an earlier demonstration with eSIM capabilities from Cubic³, a leading provider of software-defined vehicle (SDV) solutions, Viasat experts in Munich utilized advanced technology including Qualcomm Technologies Inc.’s Snapdragon® Auto 5G Modem-RF Gen 2 solution, and the Fraunhofer IIS NESC AI voice codec. This enables voice communications to be sent using the NB-IoT communications protocol over Viasat’s highly reliable, L-band satellite network.

For the first time, this technology was integrated with BMW Group’s in-vehicle architecture, allowing voice calls to be initiated and managed directly through the vehicle interface. By extending messaging and voice services beyond cellular coverage, automakers like BMW Group can ensure drivers remain connected for emergency assistance and critical safety applications, regardless of location.

“This demonstration reflects broader industry excitement to ensure consistent, resilient satellite capabilities for next-generation vehicles,” said Sandeep Moorthy, Senior Vice President, Advanced Non-Terrestrial Solutions at Viasat. “By bringing standards-based NTN to vehicles, we can integrate satellite voice and messaging and ultimately enable a future where drivers can remain connected — wherever the journey takes them.”

Viasat, BMW Group, Cubic3, and Fraunhofer IIS are active members of the 5GAA (5G Automotive Association), which brings together technology and automotive partners to develop real-world, scalable connectivity solutions for all road users. Satellite-enabled automotive connectivity applications include voice and messaging emergency services, fleet management, and over-the-air updates in low-connectivity regions.

The NB-IoT protocol, which can support lower data-rate applications, is enabled by global 3GPP standards. Future releases are expected to pave the way for 5G-New Radio (5G-NR) satellite services, which could support video streaming and seamless roaming between terrestrial and satellite networks.

About Viasat
Viasat is a global communications company that believes everyone and everything in the world can be connected. With offices in 24 countries around the world, our mission shapes how consumers, businesses, governments and militaries around the world communicate and connect. Viasat is developing the ultimate global communications network to power high-quality, reliable, secure, affordable, fast connections to positively impact people’s lives anywhere they are - on the ground, in the air or at sea, while building a sustainable future in space. In May 2023, Viasat completed its acquisition of Inmarsat, combining the teams, technologies and resources of the two companies to create a new global communications partner. Learn more at www.viasat.com, the Viasat News Room or follow us on LinkedIn, X, Instagram, Facebook, Bluesky, Threads, and YouTube.

Copyright © 2026 Viasat, Inc. All rights reserved. Viasat, the Viasat logo and the Viasat Signal are registered trademarks in the U.S. and in other countries of Viasat, Inc. All other product or company names mentioned are used for identification purposes only and may be trademarks of their respective owners.

Viasat, Inc. Contacts
Richard Jones, External Communications, Corporate & Commercial Services, [email protected] 
Lisa Curran/Peter Lopez, Investor Relations, [email protected]

About 5GAA
The 5G Automotive Association (5GAA) is a global, cross-industry organisation of companies from the automotive, technology, and telecommunications industries (ICT), working together to develop end-to-end solutions for future mobility and transportation services. Created in September 2016, 5GAA has rapidly expanded to include key players with a global footprint in the automotive, technology and telecommunications industries. This includes automotive manufacturers, tier-1 suppliers, chipset/communication system providers, mobile operators and infrastructure vendors. More information.

About Cubic3
Cubic³ brings cellular and satellite connectivity together on one platform for the automotive industry, giving software-defined vehicles (SDVs) seamless coverage across more than 200 countries and territories. With access to over 550 mobile networks, Cubic³ helps automotive OEMs navigate the complexities of global connectivity and compliance, so drivers stay connected whether they're within reach of a cellular network or relying on satellite.

Snapdragon and Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries.

Qualcomm, Qualcomm Dragonwing and Snapdragon are trademarks or registered trademarks of Qualcomm Incorporated.

Forward-Looking Statements
This press release contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933 and the Securities Exchange Act of 1934. Forward-looking statements include, among others, statements that refer to the expected benefits, capabilities, performance, availability, and future development of Viasat’s satellite-enabled automotive connectivity solutions; the successful integration and commercialization of satellite voice technology within BMW Group or any other company’s vehicles; the anticipated expansion of NTN services for automotive applications; and the connectivity to be provided by Viasat L-band satellites. Readers are cautioned that actual results could differ materially from those expressed in any forward-looking statements. Factors that could cause actual results to differ include: our ability to successfully develop, integrate, and commercialize satellite-enabled automotive technologies; risks associated with demonstrating and scaling new technologies; our ability to realize the anticipated benefits of our satellite network, including the ViaSat-3 class satellites and any future satellite we may construct or acquire; unexpected expenses related to our satellite projects; our ability to successfully implement our business plan for new and existing services on our anticipated timeline or at all; risks associated with the construction, launch and operation of satellites, including the effect of any anomaly, operational failure or degradation in satellite performance; changes in relationships with key partners, including automotive OEMs; our reliance on third parties to manufacture, supply, or integrate our solutions; increased competition and introduction of new technologies in the communications and automotive industries; changes in the global business environment and economic conditions; regulatory and spectrum-related risks, including changes affecting spectrum availability or permitted uses; our inability to access or expand use of spectrum or orbital locations; and other factors affecting the communications and automotive industries generally. In addition, please refer to the risk factors contained in our SEC filings available at www.sec.gov, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. We undertake no obligation to update or revise any forward-looking statements for any reason.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/19addb9d-bccf-4b68-9bff-fde2f0b7700e

Viasat experts demonstrate satellite-enabled voice call capabilities Viasat experts demonstrate satellite-enabled voice call capabilities as part of research collaborati...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© BigTunaOnline / Shutterstock.com

Twenty thousand dollars a month in dividends means $240,000 a year that has to arrive whether the market cooperates or not. Reaching it is a math problem before it is a stock-picking problem, and the math gets uncomfortable fast when you compare that target with current yields.

The core equation is unforgiving: annual income divided by portfolio yield equals the capital you need before taxes. Every choice from here is a negotiation between how much you have and how much risk you will accept to close the gap. For context, the 10-year Treasury recently yielded about 4.4%, which is the baseline every income strategy has to justify.

The Conservative Path: Dividend Growth at 3% to 4% At a blended 3.5% yield, hitting $240,000 requires roughly $6.86 million in invested capital. That is the ceiling of the range, and it is the price of sleep.3.1% increase to $1.34 per quarter

This tier is anchored by Dividend Kings and regulated utilities. Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) just approved a 3.1% dividend increase to $1.34 per quarter, extending 64 consecutive years of raises. The payout is backed by Q1 2026 revenue of $24.06B (+9.9% YoY) and adjusted EPS of $2.70. Southern Company (NYSE:SO) posted Q1 2026 adjusted EPS of $1.32 on revenue of $8.40B (+8.0% YoY), backed by regulated utility operations and Southeast data-center demand that CEO Chris Womack has flagged as a multi-year tailwind.$4 million

You need almost seven million dollars in capital, and half your total return still has to come from price appreciation.$0.271 monthly

The Middle Ground: REITs and Midstream at 5% to 7% Move to a blended 6% yield and the capital requirement drops to $4 million. That is the tier where net-lease REITs and pipeline partnerships live.6.6% year over year

Realty Income (NYSE:O) pays a $0.27 monthly dividend ($3.246 annualized), a yield near 5.06%, and has raised the dividend for 114 consecutive quarters. Q1 2026 AFFO/share grew 6.6% YoY to $1.13 with occupancy at 98.9%. Enterprise Products Partners yields around 6-7%, with a $0.55 quarterly distribution ($2.20 annualized, +2.8% YoY) and $5.3B of major growth projects under construction. Enterprise issues a K-1, which complicates tax filing.$30.7 billion portfolio

Dividend growth slows at this tier. Realty Income guides for 3.0-3.7% AFFO growth in 2026, which is fine but nowhere near JNJ’s historical compounding.$0.47

The Aggressive Route: BDCs at 8% to 12% Push the blended yield to 10% and you can theoretically produce $240,000 on $2.4 million. That number is seductive and should be treated with suspicion.$19.59

Ares Capital (NASDAQ:ARCC) yields around 10% and earns it from a portfolio with weighted average debt yields of 10.3% at amortized cost. Q1 core EPS of $0.47 covered the $0.48 quarterly dividend with almost no cushion, and the portfolio absorbed $412M in net unrealized losses while NAV slipped to $19.59 from $19.94. Non-accruals rose to 2.1% at amortized cost from 1.8%.

BDCs distribute what they earn from floating-rate middle-market loans. When the Fed cuts, and it has already trimmed rates over the past year, that income base compresses.

The Insight the Yield Table Hides A 3.5% portfolio that starts at $240,000 of income and raises its dividend 7% annually would pay roughly $441,000 in year ten, or about $472,000 in year eleven after ten full annual increases. A 10% portfolio that holds its distribution flat pays $240,000 every year. Ten years in, the dividend-growth investor may have far more income, while the yield chaser may have stood still if the payout never grew.

Most $20,000-a-month dividend portfolios end up blended: a conservative core to grow the income stream, a moderate sleeve to raise current yield, and a small aggressive allocation sized so a dividend cut or price decline does not break the plan.

Checks That Matter Before Chasing $20,000 a Month Recalculate the target against actual spending, not gross income. Replacing a $240,000 salary may require less than $240,000 of portfolio income once payroll taxes, retirement contributions, and work-related costs drop out. The right number is the spending gap after Social Security, pensions, cash reserves, taxes, and any part-time income.

Stress-test the aggressive tier by modeling a 20% NAV drawdown and a 15% dividend cut simultaneously. If that scenario breaks your plan, the allocation is too large.

Compare total return, not just headline yield. Pull adjusted returns for a dividend-growth holding against a double-digit BDC over the same period, then compare income growth, price change, and dividend cuts. The higher yield is not doing more work if it is offset by stagnant income or principal erosion. The Real Goal Is Durable Income A $20,000 monthly dividend target can be built with very different portfolios, but the smallest capital requirement usually carries the largest risk. The better question is not simply how to produce $240,000 this year. It is whether that income can keep arriving, keep growing, and keep surviving the parts of retirement that do not show up in a simple yield table.

Contact [email protected] for any questions or corrections.

A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet’s Omnipod products.

NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ:PODD) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet’s Omnipod products.

ShareIf you invested in Insulet, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/insulet-class-action-lawsuit.

Key Details of the Insulet ($PODD) Class Action:

Lead Plaintiff Deadline: August 31, 2026Alleged Misconduct: Securities fraud relating to the safety of Insulet’s Omnipod productsLargest Alleged Stock Drop: March 12, 2026 – 6.88% Stock DropCourt: U.S. District Court for the District of MassachusettsTake Action: Contact BFA Law to discuss your rightsInsulet investors have until August 31, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Insulet securities. The class action is pending in the U.S. District Court for the District of Massachusetts. It is captioned Hu v. Insulet Corporation et al., No. 26-cv-13062.

Why is Insulet Being Sued for Securities Fraud?

Insulet is primarily engaged in the development, manufacture, and sale of insulin delivery systems for people with insulin-dependent diabetes through its Omnipod platform. The Omnipod platform includes: the Omnipod® 5 Automated Insulin Delivery System (“Omnipod 5”), the Omnipod DASH® Insulin Management System (“Omnipod DASH”), and the Omnipod Insulin Management System (“Omnipod Eros”).

Throughout the relevant period, Insulet misrepresented the safety of its Omnipod products as well as its ability to efficiently produce “medical grade quality at consumer electronic scale.” In reality, certain of Insulet’s products suffered from undisclosed manufacturing defects that put patient safety at risk.

Why did Insulet’s Stock Drop?

On March 12, 2026, Insulet disclosed that a manufacturing issue with its Omnipod® 5 Pods caused a “tear in the internal tubing that delivers insulin” resulting in insulin being released inside the Pod “instead of being fully infused into the body as intended.” Accordingly, Insulet “initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods.”

This news caused the price of Insulet stock to drop $16.23 per share, or 6.88%, from a closing price of $236.07 per share on March 12, 2026, to $219.84 per share on March 13, 2026.

On May 26, 2026, Insulet announced another voluntary Medical Device Correction due to a manufacturing issue, this time to its Omnipod 5, Omnipod DASH, and Omnipod Eros systems. It again indicated that the manufacturing issue resulted in a tear in the tubing which “could result in insulin under-delivery.”

This news caused the price of Insulet stock to drop $7.79 per share, or 5.07%, from a closing price of $218.11 per share on May 26, 2026, to $146.01 per share on May 27, 2026.

Click here for more information: https://www.bfalaw.com/cases/insulet-class-action-lawsuit.

What Can You Do?

If you invested in Insulet, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/insulet-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/insulet-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

I initiate coverage of Alnylam Pharmaceuticals with a non-consensus BUY rating, citing the recent pullback as an overreaction. AMVUTTRA now holds a near-term commercial monopoly in TTR silencing, with strong clinical data and $890 million in Q1 2026 revenue. ALNY's robust cash position ($3.0 billion) and GAAP profitability materially reduce investment risk and support pipeline development.

This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.

Copyright 2026 Zacks Investment Research 101 N Wacker Drive, Floor 15, Chicago, IL 60606

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.

Visit Performance Disclosure for information about the performance numbers displayed above.

Visit www.zacksdata.com to get our data and content for your mobile app or website.

Real time prices by BATS. Delayed quotes by Sungard.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.

This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.

Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 16:

T. Rowe Price Group, Inc. (TROW - Free Report) : This investment management firm carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 4.3% over the last 60 days.  

T. Rowe Price Group has a price-to-earnings ratio (P/E) of 11.66 compared with 14.60 for the industry. The company possesses a Value Scoreof B.

Expro Ltd (XPRO - Free Report) : This energy services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 74% over the last 60 days.

Expro has a price-to-earnings ratio (P/E) of 17.39 compared with 21.40 for the industry. The company possesses a Value Score of A.

First Hawaiian, Inc. (FHB - Free Report) : This bank holding company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 1.7% over the last 60 days.

First Hawaiian has a price-to-earnings ratio (P/E) of 12.04 compared with 13.60 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

HomeStock IdeasLong IdeasIndustrial 

SummaryAlaska Air Group is rated Buy with a $60 fair value, reflecting a belief that current losses are driven by temporary fuel shocks.Despite a $193M Q1 loss and suspended guidance, ALK's underlying franchise—loyalty, premium, corporate, and international—continues to show robust growth.Management's 'Alaska Accelerate' plan targets $10 EPS by 2027, leveraging loyalty expansion, premium seat retrofits, and international growth to drive margin improvement.Valuation is attractive at 7.16x FY2027E earnings; risk/reward skews positive if fuel costs normalize and unit revenue holds, with Q2 results a key inflection point. ReDunnLev/iStock Editorial via Getty Images

I have an Alaska (ALK) rating of Buy and a $60 fair value based on its July 14, 2026, closing price of $46.87. I think the market is pricing in a fuel shock that will probably be temporary, and the franchise under the loss line - loyalty, premium, corporate, and

15 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Transactions Grew for the Third Straight Year But Remain a Small Slice of the Market, According to a New Realtor.com® Report

, /PRNewswire/ -- A new report from Realtor.com® finds that short sales, an alternative to foreclosure for underwater homeowners, are growing. Short sales remain a small slice of the market: fewer than 30,000 took place in the U.S. in 2025, accounting for roughly 0.6% of all typical home sales and 28% of distressed sales. Short-sale transactions rose 4% from 2023 to 2024, nearly 10% from 2024 to 2025, and about 16% year over year in the first quarter of 2026, accelerating across these three years. Even so, short sales are not the most common distressed sale, trailing foreclosures by more than two to one.

This report also found that starting in January 2026, for the first time since Realtor.com® began tracking these valuations in 2018, short sales started selling at a smaller discount than foreclosures. Distressed homes now fetch roughly 9% more of their estimated value as a short sale than as a foreclosure, a reversal of a pattern that held for nearly a decade.

Short sales let a homeowner who owes more than their home is worth sell the property for less than the remaining mortgage balance, with the lender's approval. Nearly 30,000 short sales took place in the U.S. in 2025, accounting for roughly 0.6% of all arms-length home sales and 28% of distressed sales. Despite offering real advantages for both lenders and homeowners, short sales remain far less common than foreclosures, trailing them by more than two to one.

"Even in a strong economy with home prices close to record highs, a small segment of households find themselves facing tough circumstances," said Danielle Hale, chief economist, Realtor.com®. "The good news for struggling homeowners is that they have more options now than in previous decades. A short-sale can be complicated and requires borrowers to act before the bank forces their hand; however, it benefits them by shortening the waiting period before they can qualify for a future mortgage. Foreclosures are the more common outcome, but borrowers facing difficulty should consider all of their options. Engaging with a Realtor agent who specializes in these transactions can be a smart move."

A Decade-Long Bargain, Reversed

For most of the past decade, short sales sold at a steeper discount to their estimated value than foreclosures did. Foreclosed homes sold in a fairly steady range, 25% to 30% below estimated value, year after year. The short-sale discount swung far more widely, starting around 30% in 2018, ballooning to 50% in 2022, and narrowing to roughly 20% by early 2026 as the market cooled.

The swing traces back to timing. A foreclosed home is priced by the lender the moment it sells, so its discount tracks the market in real time. A short sale is priced earlier, while the homeowner still owns it, and often sits in pending status for months while the lender decides whether to accept less than it's owed. During the rapid price run-up of 2021 and 2022, homes appreciated faster than these drawn-out deals could close, pushing short-sale discounts to their widest point. As price growth flattened in 2025 and 2026, that lag faded and the discount snapped back.

Research from the Federal Reserve Bank of Philadelphia examining the 2007-2012 housing crash found short sales sold for roughly 9% to 10% more than comparable foreclosures during that period, suggesting the current premium is less a new development than a return to the historical norm.

Why Short Sales Stay Rare

The reversal is unlikely to change how few homeowners choose a short sale. "A short sale recovers more value for the lender and does less damage to the surrounding neighborhood, but the decision isn't the lender's to make," said Glen Morgenstern, economist intern at Realtor.com®. "The homeowner controls the outcome, and a foreclosure lets them stay in the home without paying for 592 days on average. That free housing is worth more than any credit or timeline advantage a short sale offers, and the new pricing math doesn't touch that calculation."

A short sale ends earlier and requires the homeowner to actively cooperate in their own move. Short sales can release a homeowner from leftover mortgage debt and let them qualify for a new mortgage in about four years rather than seven, and while a short sale is widely believed to be gentler on a seller's credit than foreclosure, credit bureaus score the two similarly.

The ratio of short sales to foreclosures has never reached parity since Realtor.com's records began in 2006. It climbed as the 2010 Home Affordable Foreclosure Alternatives program pushed short sales as an alternative, then slid after that program ended in 2016. It has since settled at roughly four short sales for every ten foreclosures.

A Different Map Than Foreclosures

Short sales also cluster differently than foreclosures. Foreclosures concentrate in the country's most affordable markets, while short sales are scattered across moderately priced metros in the West and Florida. As of May 2026, Miami, New York, Tampa, Phoenix and Houston had the most short-sale listings. By share of listings, Lakeland, Florida led the country at 6.7%, followed by Pueblo and Colorado Springs, Colorado. Measured by completed sales, short sales are most common in Salt Lake City and Texas metros such as Austin and Dallas.

Buyers remain wary of the format. Short-sale listings draw roughly 20% fewer page views on Realtor.com than comparable homes and take about two months longer to sell, weighed down by lender approval timelines that can drag on for months and sometimes collapse before closing.

Methodology

Short sales are identified as those carrying the short-sale flag in Realtor.com deed records, and foreclosures as those carrying the REO (real estate-owned) flag, covering single-family homes, condos, townhomes, row homes and co-ops sold since 2001. Short-sale prevalence is measured both as a share of all home sales and as a share of distressed sales (short sales plus foreclosures). Short-sale listings are identified by the short-sale flag in Realtor.com listing data, consistently populated beginning in 2019.

To measure the price discount, each distressed sale price is compared against the property's estimated value from an automated valuation model, taken as the median of that property's valuations in the month three months before the sale. The discount is the percentage by which the sale price falls below that value, measured the same way for short sales and foreclosures. The short-sale premium over foreclosures is the difference between the two groups' discounts. Listing performance metrics compare each listing's statistics against the medians for its property type and ZIP code, or metro area where a ZIP has fewer than 50 listings. Sales figures reflect data through March 2026.

About Realtor.com®

For over 30 years, Realtor.com® has connected buyers, sellers, and renters with trusted insights, professional guidance and powerful tools to help them find their perfect home. Recognized as the No. 1 real estate site REALTOR® agents recommend, Realtor.com® delivers consumer connections and a robust suite of marketing tools to support business growth. Realtor.com® is operated by News Corp [Nasdaq: NWS, NWSA] [ASX: NWS, NWSLV] subsidiary Move, Inc.

Media Contact: Mallory Micetich, [email protected] 

SOURCE Realtor.com

-

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2026 financial results conference call for Thursday, July 30, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our website at investor.htgc.com. Please visit the website to test your connection before the webcast. Domestic callers can access the conference call toll free by dialing +1 (800) 267-6316. International callers can access the conference call by dialing +1 (203) 518-9783. All callers are asked to dial in 10-15 minutes prior to the call so that name and company information can be collected and to reference the conference ID HTGCQ226. For interested parties, an archived replay will be available on a webcast link located on the Investor Resources section of Hercules Capital's website.

About Hercules Capital, Inc.

Hercules Capital, Inc. (NYSE: HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology and life sciences industries. Since inception (December 2003), Hercules has committed more than $27 billion to over 700 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact [email protected], or call 650.289.3060.

Hercules, through its wholly owned subsidiary business, Hercules Adviser LLC (the “Adviser Subsidiary”), also maintains an asset management business through which it manages investments for external parties (“Adviser Funds”). The Adviser Subsidiary is registered as an investment adviser under the Investment Advisers Act of 1940.

Hercules’ common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol “HTGC.” In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE: HCXY).

More News From Hercules Capital, Inc.

Back to Newsroom

ROCKVILLE CENTRE, N.Y.--(BUSINESS WIRE)--Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (Nasdaq: GEHC) announced today a 10-year strategic partnership, known as a Care Alliance, valued at approximately $500 million, to help expand access to advanced imaging, precision diagnostics and AI-enabled technology across Catholic Health in support of innovative, compassionate and patient-centered care. This will be one of the largest Care Alliances between GE HealthCare and a leading healthcare system in the United States to date; spanning equipment, service, digital solutions, cloud solutions and AI-enabled technologies.

The Care Alliance centers on system-wide technology and equipment modernization across key Catholic Health service lines, including cardiology, oncology, neurology, and women’s health. Through this modernization, Catholic Health aims to:

Expand Catholic Health’s renowned cardiology practice by extending advanced cardiac imaging to multiple outpatient and ambulatory sites, helping improve access to high-quality cardiac services closer to home. Reduce delays in the oncology care journey by adding MR, CT, and PET technologies equipped with on-device AI solutions, with the goal of decreasing the time from diagnostic imaging to treatment. Expand nuclear medicine capabilities at Catholic Health’s St. Francis Hospital & Heart Center® and Good Samaritan University Hospital flagship locations to enhance diagnostic confidence in oncology. Add hundreds of ultrasound systems to help increase department efficiency and support clinician confidence at the point of care, including at the bedside. Enhance women's health with expanded capabilities in OB/GYN and maternal fetal medicine. A unique aspect of the Care Alliance is an embedded cardiovascular scientist that can work directly with Catholic Health clinicians to help highlight physician perspectives, clinical insights and patient care needs, potentially informing future equipment and technology considerations.

“This Care Alliance represents an important investment in the future of health care on Long Island and reflects Catholic Health’s commitment to innovating in ways that improve how care is delivered,” said Gary Havican, Interim President and CEO and Chief Operating Officer of Catholic Health. “By combining Catholic Health’s clinical expertise and commitment to compassionate, high-quality care with GE HealthCare’s advanced technology, AI-driven tools, and digital capabilities, we are enhancing our ability to deliver precision care, expand access to specialized services closer to home, and create a more seamless experience for patients and clinicians. The partnership also gives our physicians and care teams a meaningful voice in shaping the future of care so innovation is guided by real clinical and patient needs.”

As part of the 10-year Care Alliance, approximately 50% of equipment additions will arrive at Catholic Health clinical sites during the first three years of the agreement. The agreement is also expected to generate capital savings compared with traditional equipment purchasing approaches thanks to unitary payments and accelerators, which can allow Catholic Health to reinvest resources in technology modernization, expanded patient access and clinical program growth.

For patients, the partnership is designed to have a tangible impact on their clinical experience. AI-enabled tools, standardized equipment and more consistent workflows can help Catholic Health to increase capacity, reduce delays in diagnosis and treatment, improve appointment availability, and bring specialized services — including cardiology, neurology, women’s health and cancer care — closer to home.

Patients may begin to see benefits during the first year of the agreement with equipment additions expected to arrive within months, including contrast-enhanced mammography to improve access to breast imaging and biopsy services; expanded diagnostic imaging capabilities across multiple modalities; and upgraded maternal-infant care monitoring technologies at Good Samaritan University Hospital.

Clinicians will also benefit from enhanced operational support and ongoing collaboration with GE HealthCare experts to help optimize workflows, strengthen clinical decision-making and support innovation.

Beyond equipment additions and service line expansion, the Care Alliance includes comprehensive imaging, biomedical maintenance, and service support. A 10-year, multivendor service agreement will cover delivery and maintenance of equipment across 40+ sites, including lifecycle and fleet management, as well as comprehensive education and training. The agreement is designed to support Catholic Health as it maximizes uptime, boosts asset utilization, lowers lifecycle costs, increases operational efficiency, and enhances patient care. This service component helps distinguish the Care Alliance from a traditional equipment agreement, positioning GE HealthCare as a long-term partner in supporting equipment performance and reliability across the system.

The Care Alliance will also emphasize AI, cloud, and software solutions designed to deliver actionable insights and drive operational efficiency. Digital solutions included in the Care Alliance aim to reduce manual tasks, ease cognitive load for clinicians, improve clarity for patients, and create a more seamless clinical environment. One example is Imaging 360, a cloud-based radiology operations platform that unifies radiology workflows, centralizes performance insights, and enables remote scanning support. By providing a system-wide view of imaging operations, it can help multi-site health systems improve efficiency, patient access, and care consistency.

“This Care Alliance with Catholic Health is grounded in deep collaboration to expand access and advance high-quality care across Long Island,” said Rachel Gilbreath, region president, East, U.S. and Canada at GE HealthCare. “Over the next decade, we will work side-by-side to implement innovative technology and processes across the enterprise, integrate AI, cloud, and software solutions, and support clinical excellence, including cardiology, to position Catholic Health to improve outcomes and operational performance. Together, we are aligning people, process, and technology to deliver measurable impact for patients and clinicians.”

Over the course of the Care Alliance, Catholic Health will add expanded capabilities and service lines at St. Francis Hospital & Heart Center®, St. Charles Hospital, Good Samaritan University Hospital, St. Joseph Hospital, St. Catherine of Siena Hospital, and Mercy Hospital, as well as 36 other sites. Equipment will span modalities including CT, PET/CT, nuclear medicine, MR, mammography, X-ray, surgery, ultrasound, women’s health, anesthesia, diagnostic cardiology, and maternal infant care.

Catholic Health and GE HealthCare relationship

Outside of this agreement, Catholic Health and GE HealthCare have a history of working together on precision care capabilities, including Catholic Health’s early adoption of GE HealthCare’s proprietary PET agent Flyrcado™ (flurpiridaz F 18), which supports greater diagnostic confidence and more personalized care planning. In April 2025, St. Francis Hospital & Heart Center® was the first U.S. site to perform an exercise stress PET myocardial perfusion imaging study using GE HealthCare’s Flyrcado™ (flurpiridaz F 18).

For more information about GE HealthCare’s Care Alliances, visit: https://info.gehealthcare.com/carealliance

About Catholic Health

Catholic Health is an integrated system encompassing some of the region’s finest health and human services agencies. The health system has over 17,000 employees, six acute care hospitals, three nursing homes, a home health service, hospice and a network of physician practices. Under the sponsorship of the Diocese of Rockville Centre, Catholic Health serves hundreds of thousands of Long Islanders each year, providing care that extends from the beginning of life to helping people live their final years in comfort, grace and dignity. For more information, visit: https://www.catholichealthli.org.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

Important Safety Information and Usage of Flyrcado™ (flurpiridaz F 18) injection

FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION) ™ (flurpiridaz F 18) injection, for intravenous use important safety information

Indications and Usage

FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION is a radioactive diagnostic drug indicated for positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease (CAD) to evaluate for myocardial ischemia and infarction.

Contraindications

None

Warnings and Precautions

· Risk associated with exercise or pharmacologic stress: Patients evaluated with exercise or pharmacologic stress may experience serious adverse reactions such as myocardial infarction, arrhythmia, hypotension, bronchoconstriction, stroke, and seizure. Perform stress testing in the setting where cardiac resuscitation equipment and trained staff are readily available. When pharmacologic stress is selected as an alternative to exercise, perform the procedure in accordance with the pharmacologic stress agent’s prescribing information.

· Radiation risks: FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. Ensure safe handling to minimize radiation exposure to patients and health care providers. Advise patients to hydrate before and after administration and to void.

Adverse Reactions

· Most common adverse reactions occurring during FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION PET MPI under rest and stress (pharmacologic or exercise) (incidence ≥ 2%) are dyspnea, headache, angina pectoris, chest pain, fatigue, ST segment changes, flushing, nausea, abdominal pain, dizziness, and arrhythmia.

Use in Specific Populations

· Pregnancy

There are no data on use of flurpiridaz F 18 in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. If considering FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION administration to a pregnant woman, inform the patient

about the potential for adverse pregnancy outcomes based on the radiation dose from flurpiridaz F 18 and the gestational timing of exposure.

FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION contains ethanol (a maximum daily dose of 337 mg anhydrous ethanol). If considering FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes associated with ethanol exposure during pregnancy.

· Lactation

Temporarily discontinue breastfeeding. A lactating woman should pump and discard breastmilk for at least 8 hours after FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION administration.

· Pediatric Use

Safety and effectiveness of FLYRCADO™ (FLURPIRIDAZ F 18) INJECTION in pediatric patients have not been established.

To report SUSPECTED ADVERSE REACTIONS, contact GE HealthCare at 800-654-0118 (option 2 then option 1) or by email at [email protected] or FDA at 800-FDA-1088 or www.fda.gov/medwatch

For full prescribing information, click here. For important safety information, please click here.

US-Iran War Reignites — and Traders See 92% Odds of $4 Gas

The $INDEX token has surged over 150% in 24 hours, with its market cap crossing $18 million. The rally follows fresh comments from Robinhood CEO Vlad Tenev inviting developers to build with tokenized stocks and real-world assets (RWAs) on Robinhood Chain’s growing ecosystem.

How Robinhood Chain’s $INDEX Turns Chain Fees Into Stock Ownership Early reports on X put the surge down to growing awareness of $INDEX’s unique fee-to-stock yield mechanism, a model that turns on-chain trading activity directly into real stock exposure for holders.

🚨ROBINHOOD CHAIN TOKEN $INDEX SURGES 150%

The market cap of Robinhood Chain ecosystem token $INDEX has climbed above $18 million, as the token surges 150% over the past 24 hours.

The rally appears to have been fueled by Robinhood CEO Vlad Tenev’s latest comments inviting… pic.twitter.com/VMUnG97rLo

— Coin Bureau (@coinbureau) July 16, 2026

The $INDEX token is an ecosystem token on Robinhood Chain, the Arbitrum-based Layer 2 blockchain that went live on July 1, 2026. Its core mechanic is straightforward but powerful.

Trading and protocol fees generated across the chain are pooled and used to purchase Robinhood Stock Tokens, on-chain representations of equities like NVDA, GOOG, and AAPL, and those tokens are then distributed as rewards to $INDEX holders.

This makes $INDEX one of the first crypto tokens to offer real, equity-backed yield rather than inflationary token rewards.

The mechanism converts chain activity into tangible stock exposure. As Robinhood Chain processes more volume, $INDEX holders stand to receive more stock tokens.

The backdrop matters here. As CoinGape reported, Robinhood Chain Flipped Hyperliquid in 24-Hour DEX Volume just days after launch, recording over $560 million in a single day.

The chain also Hit 7.6 Million Daily Transactions, closing in fast on Base’s numbers. That kind of fee-generating activity is exactly what powers $INDEX’s stock-reward pool.

Vlad Tenev’s Developer Push Lights the Fuse The immediate trigger for the $INDEX token rally was a post on X by Robinhood CEO Vlad Tenev, who openly invited developers to build integrations with tokenized stocks and RWAs on the chain.

Tenev had earlier written: “While we’re building Robinhood Chain to be the best chain for RWA … it works great for memes too.”

While we’re building robinhood chain to be the best chain for RWA … it works great for memes too

— Vlad Tenev (@vladtenev) July 8, 2026

That framing, serious financial infrastructure that also welcomes community tokens, is exactly the narrative environment where $INDEX thrives.
Robinhood Chain has already Flipped Base to No. 2 on Uniswap, trailing only Ethereum. And meme coins like CASHCAT and HOODIE rallied among the Top Robinhood Chain Tokens This Week, showing that retail interest in the ecosystem remains strong.

$INDEX benefits from both sides of that story. High retail activity means more fees. More fees mean more Stock Tokens purchased for holders.
The $INDEX token is, in that sense, a direct bet on the entire chain’s growth, with on-chain stock exposure as the payoff.

Robinhood Chain has processed Over $3 Billion in Weekly DEX Volume, making it one of the fastest-growing Layer 2 ecosystems in 2026.

Whether the $INDEX token’s 150% surge holds will depend on how sustainable that volume is and whether the fee pool grows large enough to make the stock-reward mechanism genuinely meaningful for holders at scale.

Learn how to earn passive income with crypto through staking, lending, and more.

Key Takeaways Solana is currently changing hands around $78, representing approximately 30% gains from June’s bottom at $60.13 The token has reclaimed territory above its 50-day EMA positioned at $76.82, though the $81.50 trendline remains a barrier Speculative interest is climbing with derivatives volume increasing 15%, while ETF channels show no new capital for 48 hours Technical analysis reveals a SuperTrend buy indication—the first observed since October 2025 Japanese financial giant SBI Holdings has announced collaboration to develop blockchain-based financial systems Solana has demonstrated consistent upward momentum throughout the current week, hovering around the $78 mark following a substantial 30% appreciation from its June bottom at $60.13. This recovery phase has successfully pushed SOL above its 50-day Exponential Moving Average (EMA) positioned at $76.82, establishing this technical level as immediate price support.

Solana (SOL) Price Speculative trading activity appears to be fueling this upward movement. According to CoinGlass analytics, derivatives market volume surged 15% to reach $6.90 billion over the last 24-hour period, while Open Interest maintained stability around $4.93 billion. The current funding rate stands at 0.0040%, indicating modest bullish sentiment among leveraged traders.

Conversely, institutional participation remains subdued. Exchange-traded fund products tracking Solana have registered consecutive days without fresh capital inflows this week, indicating that traditional finance participants are adopting a wait-and-see approach.

Source: SoSoValue The critical price point under observation is $81.50. This level coincides with a declining trendline, and a definitive daily candle closure above this threshold would provide the first technical validation that the bearish trajectory is reversing. Should bulls successfully breach this barrier, subsequent price objectives include $83.81, followed by the 78.6% Fibonacci retracement level at $88.56.

Critical Resistance Zone Between $89 and $92 A more substantial challenge awaits at higher levels. The $89 to $92 price corridor has repeatedly repelled upward advances since March, establishing it as a formidable obstacle that bulls must overcome before $100 becomes a realistic target. The 200-day EMA currently positioned at $94.52 further reinforces this resistance cluster.

Crypto analyst Ali Martinez highlighted that the SuperTrend technical indicator has generated its inaugural buy signal since October 2025. His technical assessment suggests potential price objectives near $96 and $121 if consistent purchasing pressure materializes.

SOLANA TURNED BULLISH

The ATR trailing stop has flipped below price, marking the first SuperTrend buy signal since October 10.

If buying pressure continues to build, $SOL could rally toward $96 or even $121. However, $60 remains the key level to watch.

A break below that… https://t.co/Femtlawn2r pic.twitter.com/pJSFngWZiN

— Ali Charts (@alicharts) July 15, 2026

Market analyst Michaël van de Poppe emphasized the significance of the present price zone, stating on X that maintaining current levels could facilitate a move toward $120 over the upcoming months. He attributed this optimistic outlook to the recent market-wide recovery that has improved overall trading conditions.

$SOL holds this crucial level for support and makes it therefore increasingly more likely that it continues to run to $120 in the coming 1-2 months. https://t.co/PPFJXcDUIi

— Michaël van de Poppe (@CryptoMichNL) July 15, 2026

Strategic Alliance with SBI Holdings Solana received additional positive momentum through a newly announced institutional collaboration. SBI Holdings, a prominent Japanese financial services corporation, has entered into a strategic partnership with the Solana network to develop blockchain-based financial infrastructure. This initiative encompasses stablecoin integration, real-world asset tokenization, international settlement systems, and payment solutions for artificial intelligence agents.

Decentralized exchange platforms operating on Solana processed approximately $4.15 billion in trading volume during a 24-hour measurement period, positioning the network favorably compared to competing blockchain ecosystems in terms of this performance metric.

Regarding downside scenarios, the $74–$75 price band represents the crucial support area requiring attention. Technical analyst BitGuru identified this zone on X as a significant near-term foundation. A breakdown beneath this range could trigger downward movement toward $68.88, with June’s low at $60.13 serving as the more substantial structural support level.

The Relative Strength Index currently registers near 54, demonstrating modest positive momentum while remaining outside overbought territory. The MACD indicator is converging with its signal line, maintaining a relatively neutral technical posture.

Premier Foods LON: PFD said first-quarter sales rose as growth in its branded portfolio offset continued pruning of lower-margin non-branded grocery contracts, and the company left its trading profit expectations for the year unchanged.

Chief Executive Alex Whitehouse told analysts that the update covered the 13 weeks to June 27 and said the company was “on track at this early stage in the year.” Group sales increased 2.7%, while U.K. branded sales rose 3.8%. Overall branded sales were up 4%, which Whitehouse said was ahead of the market and helped the company gain further market share.

Whitehouse attributed the performance to Premier Foods’ “Branded Growth Model,” which he described as a focus on leading brands, consumer-led product development, advertising and marketing, digital engagement and close work with retailers on category growth and in-store execution.

Get Premier Foods alerts:

Sweet Treats Led by Mr Kipling Growth Branded sweet treats sales rose 6.6% in the quarter, led by Mr Kipling, which grew by more than 9%. Whitehouse said Premier Foods’ branded sweet treats have now grown by an average of 8% over the last 11 quarters.

He said innovation continued to support the category, alongside strength in the core product ranges. Recent launches included Mr Kipling Birthday Cake Slices, which followed the company’s Birthday Cake Tarts, and a new range of Mr Kipling Whirls in flavors including Cookies & Cream. Whitehouse said the birthday cake flavor was inspired by a trend observed in the U.S., while the Whirls range was designed to appeal to younger consumers.

Other recent innovation included Mr Kipling Cake Bites, aimed at sharing and portion control, and Mr Kipling Breakfast Bakes, which the company said target a different time of day from much of the brand’s existing consumption.

Grocery Brands Grow, Non-Branded Business Still Being Reshaped Premier Foods’ branded grocery sales increased 3% from a year earlier. New products included Ambrosia custard pouches, which Whitehouse described as convenient lunchbox options containing 100 calories per pouch; Loyd Grossman premium cooking sauce kits in a three-step format; and Nissin Kanzen meals in a pot, which he said contain more than 20 grams of protein and 26 essential vitamins and minerals.

The company also cited contributions from products launched last year, including OXO Bone Broth and Angel Delight Bubble Jelly, which Whitehouse said supported sales growth and share gains.

Non-branded sweet treats sales increased 5.3%, helped by stronger volumes in pies and tarts and a contract win for cake slices. Whitehouse said the company now expects modest growth in non-branded sweet treats for the year.

Non-branded grocery sales were GBP 2.5 million lower in the quarter as Premier Foods continued to exit some contracts. Whitehouse said the company has been “right-sizing” that part of the business, with a medium-term aim for non-branded operations to be flat or deliver modest low-single-digit growth.

In response to a question from Jefferies analyst Andrew Wade, Whitehouse said the exited contracts represented “relatively hollow revenue” with little or no profit impact. He said the non-branded grocery business is now smaller but “significantly more profitable,” though it will take longer to complete that process than in sweet treats.

Acquired Brands and New Categories Continue to Expand Sales in new categories increased 16% from last year, following 38% growth in the comparable period a year earlier. Whitehouse highlighted Cape Herb & Spice as a strong performer, saying it had become an established presence in the market and helped reduce seasonality in the grocery business by supporting meals and barbecue occasions.

He also pointed to FUEL10K yogurt and granola, a chilled product launched last year that combines protein-enriched yogurt with granola in a separate lid.

Premier Foods said its three acquired brands — The Spice Tailor, FUEL10K and Merchant Gourmet — each grew sales by double digits in the quarter. Merchant Gourmet saw growth across its range, including new Gourmet Baked Beans. FUEL10K continued to gain share in granola, with Whitehouse noting that its Chocolate Granola remained the No. 1 granola product in the U.K. market. The Spice Tailor’s core Indian kits range also performed strongly, with brand sales growing in the teens percentage range.

Whitehouse said the company continues to look for acquisition opportunities in “future focused brands” where it can apply its branded growth model, while noting that Premier Foods remains selective.

International Sales Rise as Australia Stabilizes International sales rose 6% at constant currency and 7% on a reported basis. Whitehouse said Premier Foods’ focus markets remain Australasia, North America and EMEA, with attention on Mr Kipling, Sharwood’s, The Spice Tailor and FUEL10K.

In Europe, sales grew by double digits, supported by the launch of FUEL10K in the Netherlands, Germany and France. Whitehouse said the Netherlands had achieved the most significant distribution, with granola and porridge pots listed in Albert Heijn.

North America also delivered double-digit growth. In Canada, Premier Foods saw higher sales of The Spice Tailor, while in the U.S. growth reflected new distribution for Mr Kipling slices and pies that began in the second half of last year, as well as more recent listings.

In Australia, The Spice Tailor sales grew more than 20%, helped by a multi-channel marketing campaign that included television advertising and a retail experience in a major shopping center. Whitehouse said cake sales in Australia had stabilized as retailer stock levels began to normalize.

Asked by Investec analyst Matthew Webb why international growth was 6% despite double-digit growth in several regions, Whitehouse said Australia is a much larger and more established market for Premier Foods, and overall sales there were “pretty flat” as stock levels continued to normalize. He said the outcome was better than expected and that the company had made progress working with retailers on logistics and ordering levels.

Q&A: Ireland, Input Costs and Easter Timing Peel Hunt analyst Charles Hall asked about Ireland, where Premier Foods moved from a distributor arrangement to direct retail delivery with a significant retailer. Whitehouse said the change created a one-off first-quarter impact as distributor stocks were run down, amounting to “a couple of million GBP or so” of branded grocery sales. He said the direct relationship is more efficient, saves money and gives the company more control.

On input costs and pricing, Whitehouse said the picture was similar to previous guidance. While the company was monitoring developments closely, he said it did not currently appear to need pricing action.

Wade also asked about the cadence of innovation. Whitehouse said there had been a “subtle change” over several years, with Premier Foods focusing less on the absolute number of new products and more on ideas with greater potential scale. He cited OXO Bone Broth as a product the company expects can scale to several million pounds of turnover.

Webb asked about the timing of Easter, noting prior comments that some sales had benefited the previous fourth quarter. Whitehouse confirmed that deliveries ahead of Easter had boosted the fourth quarter at the expense of the first quarter, and said first-quarter branded grocery and sweet treats would have been stronger on a like-for-like Easter timing basis.

Whitehouse closed the call by saying the first quarter is not Premier Foods’ largest period, with demand typically stronger later in the year when weather turns colder, but said the company was “off to a good start” and reiterated that there was no change to the outlook for the year.

About Premier Foods LON: PFDPremier Foods plc, together with its subsidiaries, manufactures and distributes branded and own label food products in the United Kingdom, other European countries, and internationally. The company operates through Grocery, Sweet Treats, and international segments. It offers a portfolio of product categories, including flavorings and seasonings under the Bisto, OXO, Paxo, and Saxa brands; cooking sauces and accompaniments under the Sharwood's, Loyd Grossman, Spice Tailor and Homepride brands; quick meals, snacks, and soups under the Batchelors and Smash brands; ambient desserts under the Ambrosia, Bird's, and Angel Delight brands; and ambient cakes under the Mr Kipling and Cadbury brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Premier Foods Right Now?Before you consider Premier Foods, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Premier Foods wasn't on the list.

While Premier Foods currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Silver prices (XAG/USD) fell on Thursday, according to FXStreet data. Silver trades at $57.00 per troy ounce, down 1.34% from the $57.77 it cost on Wednesday.

Silver prices have decreased by 19.82% since the beginning of the year.

The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, stood at 70.78 on Thursday, up from 70.29 on Wednesday.

Silver FAQs Silver is a precious metal highly traded among investors. It has been historically used as a store of value and a medium of exchange. Although less popular than Gold, traders may turn to Silver to diversify their investment portfolio, for its intrinsic value or as a potential hedge during high-inflation periods. Investors can buy physical Silver, in coins or in bars, or trade it through vehicles such as Exchange Traded Funds, which track its price on international markets.

Silver prices can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can make Silver price escalate due to its safe-haven status, although to a lesser extent than Gold's. As a yieldless asset, Silver tends to rise with lower interest rates. Its moves also depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAG/USD). A strong Dollar tends to keep the price of Silver at bay, whereas a weaker Dollar is likely to propel prices up. Other factors such as investment demand, mining supply – Silver is much more abundant than Gold – and recycling rates can also affect prices.

Silver is widely used in industry, particularly in sectors such as electronics or solar energy, as it has one of the highest electric conductivity of all metals – more than Copper and Gold. A surge in demand can increase prices, while a decline tends to lower them. Dynamics in the US, Chinese and Indian economies can also contribute to price swings: for the US and particularly China, their big industrial sectors use Silver in various processes; in India, consumers’ demand for the precious metal for jewellery also plays a key role in setting prices.

Silver prices tend to follow Gold's moves. When Gold prices rise, Silver typically follows suit, as their status as safe-haven assets is similar. The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, may help to determine the relative valuation between both metals. Some investors may consider a high ratio as an indicator that Silver is undervalued, or Gold is overvalued. On the contrary, a low ratio might suggest that Gold is undervalued relative to Silver.

JB Hunt Transport reported quarterly earnings of $1.91 per share, which beat the analyst estimate of $1.71 by 11.7%, according to Benzinga Pro data. Quarterly revenue came in at $3.5 billion, which beat the Street estimate of $3.24 billion and was up from $2.93 billion in the same period last year.

J B Hunt Transport Services shares jumped 7.9% to $298.14 in pre-market trading.

Here are some other stocks moving in pre-market trading.

GainersLosersPhoto via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

AST SpaceMobile stock has fallen 27% in the past three months and its latest debt offering isn't helping.

EURGBP edges higher in early Thursday after hitting 13-month low following 0.8% drop on Wednesday (the biggest daily loss since June 22), when the pound was strongly lifted by signals that new PM Burnham will pick a fiscally conservative finance minister to be in charge of handling fragile public finances.

Oversold daily studies contributed to partial profit-taking after strong fall on Wednesday, with limited upticks seen rather as positioning for fresh push lower, as larger downtrend remains intact.

Technical picture on daily chart remains bearish, though with overstretched momentum studies that open way for some corrective action.

Falling 10DMA (0.8520) should ideally cap and guard upper breakpoints at 0.8550 zone (broken 50% retracement of 0.8222/0.8865 rally / 100WMA), violation of which may sideline larger bears for stronger bounce that would unmask next key barriers at 0.8600/10 zone (200WMA / former range floor and higher base).

Firm break of cracked Fibo support at 0.8467 (61.8% of 0.8222/0.8865) where bears faced strong headwinds on Wednesday / today, would signal continuation of larger downtrend and expose targets at 0.8373 (Fibo 76.4%) and 0.8355 (29 May 2025 low).

Res: 0.8500; 0.8520; 0.8550; 0.8600
Sup: 0.8467; 0.8449; 0.8373; 0.8355

Windsor Brokers Ltdhttp://www.windsorbrokers.com/

The information contained in this document was obtained from sources believed to be reliable, but its accuracy or completeness cannot be guaranteed. Any opinions expressed herein are in good faith, but are subject to change without notice. No liability accepted whatsoever for any direct or consequential loss arising from the use of this document.

ING strategists Warren Patterson and Ewa Manthey report Gold has risen for a second session as softer US producer price data weighs on the Dollar and Treasury yields, reducing expectations of near-term Federal Reserve tightening. Markets now assign a much lower probability to a July rate hike, which supports Gold. However, they caution that ongoing Middle East tensions and elevated energy prices could limit upside.

Lower Fed odds aid bullion"Gold rose for a second straight session as softer-than-expected US producer price data weighed on the dollar and Treasury yields."

"Lower energy costs helped ease inflation pressures, reducing expectations of near-term Federal Reserve tightening."

"Markets now price only a 12% chance of a July rate hike, down from almost 31% a week ago. Lower rate expectations are supportive for gold."

"But we believe upside could remain limited in the near term if Middle East tensions continue to support energy prices and keep inflation risks elevated."

(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor. Know more.)